HLS Therapeutics Inc.
HLTRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $11 | $12 | $18 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $8 | $9 | $8 | $8 |
| Inventory | $7 | $7 | $7 | $9 |
| Other Curr. Assets | $1 | $2 | $1 | $1 |
| Total Curr. Assets | $27 | $30 | $34 | $35 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $110 | $116 | $117 | $122 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $1 | $1 | $1 | $1 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $113 | $119 | $120 | $125 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $140 | $149 | $154 | $160 |
| Liabilities | – | – | – | – |
| Payables | $11 | $8 | $9 | $9 |
| Short-Term Debt | $5 | $6 | $6 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $13 | $9 | $8 |
| Total Curr. Liab. | $23 | $28 | $24 | $23 |
| LT Debt | $49 | $49 | $58 | $61 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $4 | $4 | $4 | $4 |
| Other NC Liab. | $2 | $1 | $1 | $1 |
| Total NC Liab. | $55 | $55 | $63 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $78 | $83 | $87 | $89 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $256 | $258 | $260 | $261 |
| Retained Earnings | -$203 | -$200 | -$198 | -$194 |
| AOCI | -$8 | -$6 | -$10 | -$10 |
| Other Equity | $16 | $15 | $15 | $15 |
| Total Equity | $62 | $67 | $67 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $140 | $149 | $154 | $160 |
| Net Debt | $43 | $43 | $46 | $49 |